59 related articles for article (PubMed ID: 35929830)
1. M1 macrophage-derived exosomes synergistically enhance the anti- bladder cancer effect of gemcitabine.
Tang Z; Tang C; Sun C; Ying X; Shen R
Aging (Albany NY); 2022 Aug; 14(18):7364-7377. PubMed ID: 35929830
[TBL] [Abstract][Full Text] [Related]
2. M1 macrophage-derived exosome-encapsulated cisplatin can enhance its anti-lung cancer effect.
Li J; Li N; Wang J
Minerva Med; 2023 Oct; 114(5):634-641. PubMed ID: 32272830
[TBL] [Abstract][Full Text] [Related]
3. Berberine modulates the immunometabolism and differentiation of CD4
Cai WW; Gao Y; Cheng JW; Yu Y; Zong SY; Li YH; Wang Y; Song YN; Mao XT; Guan J; Xu L; Zhang DY; Li K; Wei F
Phytomedicine; 2024 Feb; 124():155255. PubMed ID: 38181528
[TBL] [Abstract][Full Text] [Related]
4. M1 intestinal macrophages-derived exosomes promote colitis progression and mucosal barrier injury.
Du R; Chen S; Han C; He Z; Pei H; Yang Y
Aging (Albany NY); 2024 Mar; 16(6):5703-5710. PubMed ID: 38535999
[TBL] [Abstract][Full Text] [Related]
5. Manipulating macrophage polarization with nanoparticles to control metastatic behavior in heterotypic breast cancer micro-tissues
Sungu M; Isik M; Güler Ü; Eylem CC; Eskizengin H; Nemutlu E; Salih B; Derkus B
Nanoscale; 2023 Dec; 16(1):394-410. PubMed ID: 38073471
[TBL] [Abstract][Full Text] [Related]
6. Macrophage derived Exosomal Docetaxel (Exo-DTX) for pro-metastasis suppression: QbD driven formulation development, validation, in-vitro and pharmacokinetic investigation.
Basak M; Narisepalli S; Salunkhe SA; Tiwari S; Chitkara D; Mittal A
Eur J Pharm Biopharm; 2024 Feb; 195():114175. PubMed ID: 38185191
[TBL] [Abstract][Full Text] [Related]
7. PA-MSHA induces apoptosis and suppresses metastasis by tumor associated macrophages in bladder cancer cells.
Liu J; Duan X
Cancer Cell Int; 2017; 17():76. PubMed ID: 28824336
[TBL] [Abstract][Full Text] [Related]
8. Antitumor Activity of Cabazitaxel and MSC-TRAIL Derived Extracellular Vesicles in Drug-Resistant Oral Squamous Cell Carcinoma.
Qiu Y; Sun J; Qiu J; Chen G; Wang X; Mu Y; Li K; Wang W
Cancer Manag Res; 2020; 12():10809-10820. PubMed ID: 33149686
[TBL] [Abstract][Full Text] [Related]
9. Oblongifolin C reverses GEM resistance via suppressing autophagy flux in bladder cancer cells.
Huang Z; Wang T; Xia W; Li Q; Chen X; Liu X; Wei P; Xu W; Lv M
Exp Ther Med; 2020 Aug; 20(2):1431-1440. PubMed ID: 32765672
[TBL] [Abstract][Full Text] [Related]
10. Electrospun nanofibrous mats loaded with gemcitabine and cisplatin suppress bladder tumor growth by improving the tumor immune microenvironment.
Wang J; Yin Y; Ren X; Wang S; Zhu Y
J Mater Sci Mater Med; 2024 Mar; 35(1):21. PubMed ID: 38526656
[TBL] [Abstract][Full Text] [Related]
11. Iron Oxide Nanoparticles Engineered Macrophage-Derived Exosomes for Targeted Pathological Angiogenesis Therapy.
Zhang H; Mao Y; Nie Z; Li Q; Wang M; Cai C; Hao W; Shen X; Gu N; Shen W; Song H
ACS Nano; 2024 Mar; 18(10):7644-7655. PubMed ID: 38412252
[TBL] [Abstract][Full Text] [Related]
12. Reactive myelopoiesis and FX-expressing macrophages triggered by chemotherapy promote cancer lung metastasis.
Wu C; Zhong Q; Shrestha R; Wang J; Hu X; Li H; Rouchka EC; Yan J; Ding C
JCI Insight; 2023 May; 8(9):. PubMed ID: 36976637
[TBL] [Abstract][Full Text] [Related]
13. Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis.
Zhang W; Wan Z; Qu D; Sun W; Zhang L; Liang Y; Pan L; Jiang H; Ye Z; Wei M; Yuan L; Yang G; Jin F
Bioact Mater; 2024 Feb; 32():488-501. PubMed ID: 37965241
[TBL] [Abstract][Full Text] [Related]
14. Effect and Mechanism of Curdione Combined with Gemcitabine on Migration and Invasion of Bladder Cancer.
Chi BJ; Duan ZL; Hasan AHAM; Yin XZ; Cui BY; Wang FF
Biochem Genet; 2023 Dec; ():. PubMed ID: 38049684
[TBL] [Abstract][Full Text] [Related]
15. A Novel Cargo Delivery System-AnCar-Exo
Li S; Wu YR; Peng XQ; Chen HG; Zhang TY; Chen H; Yang J; Xie YL; Qi HB; Xiang W; Huang B; Zhou SR; Hu Y; Tan QY; Du XL; Huang JL; Zhang RB; Li XH; Luo FT; Jin M; Su N; Luo XQ; Huang S; Yang P; Yan XJ; Lian JQ; Zhu Y; Xiong Y; Xiao GY; Liu YY; Shen C; Kuang L; Ni ZH; Chen L
Adv Sci (Weinh); 2024 Feb; 11(7):e2306143. PubMed ID: 38083984
[TBL] [Abstract][Full Text] [Related]
16. Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms.
Yin C; Liufu C; Zhu T; Ye S; Jiang J; Wang M; Wang Y; Shi B
Int J Nanomedicine; 2024; 19():3677-3695. PubMed ID: 38681092
[TBL] [Abstract][Full Text] [Related]
17. A sialyltransferases-related gene signature serves as a potential predictor of prognosis and therapeutic response for bladder cancer.
Cao P; Chen M; Zhang T; Zheng Q; Liu M
Eur J Med Res; 2023 Nov; 28(1):515. PubMed ID: 37968767
[TBL] [Abstract][Full Text] [Related]
18. Phytochemicals and Cancer Treatment: Cell-Derived and Biomimetic Vesicles as Promising Carriers.
Baldassari S; Balboni A; Drava G; Donghia D; Canepa P; Ailuno G; Caviglioli G
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242687
[TBL] [Abstract][Full Text] [Related]
19. Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy.
Yang Y; Wang Q; Zou H; Chou CK; Chen X
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111560
[TBL] [Abstract][Full Text] [Related]
20. The Potential Use of Exosomes in Anti-Cancer Effect Induced by Polarized Macrophages.
Abe C; Bhaswant M; Miyazawa T; Miyazawa T
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
